학술논문
A systematic review of higher-risk myelodysplastic syndromes clinical trials to determine the benchmark of azacitidine and explore alternative endpoints for overall survival
Document Type
Article
Author
Source
In Leukemia Research May 2021 104
Subject
Language
ISSN
0145-2126